-
N135851-25gPalmitoylethanolamide is an endogenous cannabinoid. It is a weak ligand of the cannabinoid 1 (CB1) and cannabinoid 2 (CB2) receptors. It has been found to inhibit FAAH (fatty acid amide hydrolase). Palmitoylethanolamide exhibits anti-nociceptive,
-
N135851-50mgPalmitoylethanolamide is an endogenous cannabinoid. It is a weak ligand of the cannabinoid 1 (CB1) and cannabinoid 2 (CB2) receptors. It has been found to inhibit FAAH (fatty acid amide hydrolase). Palmitoylethanolamide exhibits anti-nociceptive,
-
N135851-5gPalmitoylethanolamide is an endogenous cannabinoid. It is a weak ligand of the cannabinoid 1 (CB1) and cannabinoid 2 (CB2) receptors. It has been found to inhibit FAAH (fatty acid amide hydrolase). Palmitoylethanolamide exhibits anti-nociceptive,
-
P424639-1mlPalmitoylethanolamide is an endogenous cannabinoid. It is a weak ligand of the cannabinoid 1 (CB1) and cannabinoid 2 (CB2) receptors. It has been found to inhibit FAAH (fatty acid amide hydrolase). Palmitoylethanolamide exhibits anti-nociceptive,
-
P334984-1gPalmityl acetate.
-
P334984-25gPalmityl acetate.
-
P334984-5gPalmityl acetate.
-
P352340-100mgPalmityl dodecanoate.
-
P352340-500mgPalmityl dodecanoate.
-
P100622-25gPalmityl palmitate.
-
P100622-5gPalmityl palmitate.
-
P100623-100gPalmityl palmitate.